Greg Harrison
Stock Analyst at Scotiabank
(0)
# 4443
Out of 5,319 analysts
84
Total ratings
35.00%
Success rate
-16.65%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
UTHR United Therapeutics | Upgrades: Neutral | 314 314 | 284.73 | 10.28% | 2 | Apr 21, 2025 | |
APLS Apellis Pharmaceutic... | Maintains: Sector Perform | 30 31 | 18.2 | 70.33% | 3 | Apr 2, 2025 | |
TVTX Travere Therapeutics | Maintains: Strong Buy | 29 31 | 14.92 | 107.77% | 9 | Apr 1, 2025 | |
ALNY Alnylam Pharmaceutic... | Maintains: Sector Outperform | 338 342 | 234.56 | 45.8% | 5 | Mar 31, 2025 | |
LQDA Liquidia | Maintains: Sector Outperform | 30 34 | 13.72 | 147.81% | 5 | Mar 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Sector Outperform | 40 | 17 | 135.29% | 5 | Mar 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 51 52 | 6.33 | 721.48% | 4 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 73 75 | 42.16 | 77.89% | 4 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 6 4 | 1.27 | 214.96% | 2 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 49 52 | 33.87 | 53.53% | 5 | Feb 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Perform | 433 450 | 489.1 | -7.99% | 5 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 44 41 | 14.07 | 191.4% | 5 | Jan 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sector Outperform | 53 75 | 27.66 | 171.15% | 4 | Dec 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 60 | 21.29 | 181.82% | 1 | Oct 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 18 | 5.67 | 217.46% | 1 | Oct 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sector Outperform | 22 | 7.31 | 200.96% | 1 | Oct 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 13 15 | 1.28 | 1071.88% | 3 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 89 91 | 7.23 | 1158.64% | 2 | Jun 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 7.69 | 56.05% | 3 | May 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 5 2 | 0.71 | 111.27% | 1 | Apr 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 39 | 13.35 | 192.13% | 1 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3 | 6.78 | -55.75% | 1 | Nov 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 70 | 3.88 | 1704.12% | 1 | Sep 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 20 | n/a | n/a | 2 | Sep 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 8 | 29.11 | -72.52% | 1 | Jun 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Jun 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 25 7 | n/a | n/a | 4 | May 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 67 54 | 16.82 | 221.05% | 1 | Mar 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 18 6 | 0.64 | 837.5% | 2 | Mar 14, 2022 |